Metalaxyl

CASRN 57837-19-1

IRIS Summary (PDF) (8 pp, 92 K)
Status: Metalaxyl is not being reassessed by IRIS at this time.
Reregistration Eligibility Decision (RED) (PDF) (335 pp, 157 K)

Key IRIS Values

Health Hazard Assessments for Effects Other than Cancer

Reference Dose for Oral Exposure (RfD) (PDF) (8 pp, 92 K) last updated: 01/31/1987

RfD (mg/kg-day)	System	Basis	PoD	Composite UF	Confidence
6 x10^-2	Hepatic	Increased serum alkaline phosphatase levels and increased liver-to-brain weight ratio	NOEL : 6.25 mg/kg-day	100	High

Reference Concentration for Inhalation Exposure (RfC) (PDF) (8 pp, 92 K)
Not assessed under the IRIS Program.

Cancer Assessment

Weight of Evidence for Cancer (PDF) (8 pp, 92 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (8 pp, 92 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (8 pp, 92 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.